1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
- Clinical aspects of molecular profiles in metastatic malignant melanoma
- 2016
- Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer
- 2013
- Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma
- 2007
- Confirmation of a BRAF mutation-associated gene expression signature in melanoma
- 2004
- Microarray expression profiling in melanoma reveals a BRAF mutation signature